BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21887643)

  • 1. Cyclic lipopeptide profile of three Bacillus subtilis strains; antagonists of Fusarium head blight.
    Dunlap CA; Schisler DA; Price NP; Vaughn SF
    J Microbiol; 2011 Aug; 49(4):603-9. PubMed ID: 21887643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coproduction of surfactin and iturin A, lipopeptides with surfactant and antifungal properties, by Bacillus subtilis.
    Sandrin C; Peypoux F; Michel G
    Biotechnol Appl Biochem; 1990 Aug; 12(4):370-5. PubMed ID: 2119191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESI LC-MS and MS/MS characterization of antifungal cyclic lipopeptides produced by Bacillus subtilis XF-1.
    Li XY; Mao ZC; Wang YH; Wu YX; He YQ; Long CL
    J Mol Microbiol Biotechnol; 2012; 22(2):83-93. PubMed ID: 22614917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of a Bacillus subtilis Strain Producing Multiple Types of Cyclic Lipopeptides and Evaluation of Their Surface-tension-lowering Activities.
    Habe H; Taira T; Imura T
    J Oleo Sci; 2017; 66(7):785-790. PubMed ID: 28674328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of chlamydospore formation in fusarium by cyclic lipopeptide antibiotics from Bacillus subtilis C2.
    Li L; Ma M; Huang R; Qu Q; Li G; Zhou J; Zhang K; Lu K; Niu X; Luo J
    J Chem Ecol; 2012 Aug; 38(8):966-74. PubMed ID: 22932866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative analysis of biosurfactants from Bacillus species exhibiting antifungal activity.
    Sarwar A; Brader G; Corretto E; Aleti G; Ullah MA; Sessitsch A; Hafeez FY
    PLoS One; 2018; 13(6):e0198107. PubMed ID: 29864153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel surfactin derivatives from NRPS modification of Bacillus subtilis and its antifungal activity against Fusarium moniliforme.
    Jiang J; Gao L; Bie X; Lu Z; Liu H; Zhang C; Lu F; Zhao H
    BMC Microbiol; 2016 Mar; 16():31. PubMed ID: 26957318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Fusarium graminearum inhibitory lipopeptide from Bacillus subtilis IB.
    Wang J; Liu J; Chen H; Yao J
    Appl Microbiol Biotechnol; 2007 Sep; 76(4):889-94. PubMed ID: 17611753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of biosurfactant lipopeptides Iturin A, fengycin and surfactin A from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides.
    Kim PI; Ryu J; Kim YH; Chi YT
    J Microbiol Biotechnol; 2010 Jan; 20(1):138-45. PubMed ID: 20134245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first report of antifungal lipopeptide production by a Bacillus subtilis subsp. inaquosorum strain.
    Knight CA; Bowman MJ; Frederick L; Day A; Lee C; Dunlap CA
    Microbiol Res; 2018 Nov; 216():40-46. PubMed ID: 30269855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory activity of bacterial lipopeptides against Fusarium oxysporum f.sp. Strigae.
    Assena MW; Pfannstiel J; Rasche F
    BMC Microbiol; 2024 Jun; 24(1):227. PubMed ID: 38937715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis FR-2.
    Kajimura Y; Sugiyama M; Kaneda M
    J Antibiot (Tokyo); 1995 Oct; 48(10):1095-103. PubMed ID: 7490214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postharvest Biological Control of Colletotrichum acutatum on Apple by Bacillus subtilis HM1 and the Structural Identification of Antagonists.
    Kim HM; Lee KJ; Chae JC
    J Microbiol Biotechnol; 2015 Nov; 25(11):1954-9. PubMed ID: 26428548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Production of Two Anti-
    Ramchandran R; Ramesh S; A A; Thakur R; Chakrabarti A; Roy U
    Curr Pharm Biotechnol; 2020; 21(5):438-450. PubMed ID: 31804165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal Competitors Affect Production of Antimicrobial Lipopeptides in Bacillus subtilis Strain B9-5.
    DeFilippi S; Groulx E; Megalla M; Mohamed R; Avis TJ
    J Chem Ecol; 2018 Apr; 44(4):374-383. PubMed ID: 29492723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, sequencing, and characterization of the genetic region relevant to biosynthesis of the lipopeptides iturin A and surfactin in Bacillus subtilis.
    Yao S; Gao X; Fuchsbauer N; Hillen W; Vater J; Wang J
    Curr Microbiol; 2003 Oct; 47(4):272-7. PubMed ID: 14629006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Yield and Surface Tension-lowering Activity of Iturin A Produced by Bacillus subtilis RB14.
    Habe H; Taira T; Sato Y; Imura T; Ano T
    J Oleo Sci; 2019 Nov; 68(11):1157-1162. PubMed ID: 31611518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopeptides from an isolate of Bacillus subtilis complex have inhibitory and antibiofilm effects on Fusarium solani.
    Santos-Lima D; de Castro Spadari C; de Morais Barroso V; Carvalho JCS; de Almeida LC; Alcalde FSC; Ferreira MJP; Sannomiya M; Ishida K
    Appl Microbiol Biotechnol; 2023 Oct; 107(19):6103-6120. PubMed ID: 37561179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis.
    Klich MA; Lax AR; Bland JM
    Mycopathologia; 1991 Nov; 116(2):77-80. PubMed ID: 1780001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopeptide mediated biocontrol activity of endophytic Bacillus subtilis against fungal phytopathogens.
    Hazarika DJ; Goswami G; Gautom T; Parveen A; Das P; Barooah M; Boro RC
    BMC Microbiol; 2019 Apr; 19(1):71. PubMed ID: 30940070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.